4.4 Article

Glucose Variability Assessed with Continuous Glucose Monitoring: Reliability, Reference Values, and Correlations with Established Glycemic Indices-The Maastricht Study

期刊

DIABETES TECHNOLOGY & THERAPEUTICS
卷 22, 期 5, 页码 395-403

出版社

MARY ANN LIEBERT, INC
DOI: 10.1089/dia.2019.0385

关键词

Continuous glucose monitoring; Epidemiology; Glucose variability; Oral glucose tolerance test; Reference values; Reliability; Type 2 diabetes mellitus

资金

  1. European Regional Development Fund via OP-Zuid
  2. Province of Limburg
  3. Dutch Ministry of Economic Affairs [31O.041]
  4. Stichting De Weijerhorst (Maastricht, the Netherlands)
  5. Pearl String Initiative Diabetes (Amsterdam, the Netherlands)
  6. School for Cardiovascular Diseases (CARIM, Maastricht, the Netherlands)
  7. Care and Public Health Research Institute (CAPHRI, Maastricht, the Netherlands)
  8. School for Nutrition and Translational Research in Metabolism (NUTRIM, Maastricht, the Netherlands)
  9. Stichting Annadal (Maastricht, the Netherlands)
  10. Health Foundation Limburg (Maastricht, the Netherlands)
  11. Janssen-Cilag B.V. (Tilburg, the Netherlands)
  12. Novo Nordisk Farma B.V. (Alphen aan den Rijn, the Netherlands)
  13. Sanofi-Aventis Netherlands B.V. (Gouda, the Netherlands)
  14. Medtronic (Tolochenaz, Switzerland)

向作者/读者索取更多资源

Background: Glucose variability (GV) measured by continuous glucose monitoring (CGM) has become an accepted marker of glycemic control. Nevertheless, several methodological aspects of GV assessment require further study. We, therefore, investigated the minimum number of days needed to reliably measure GV, assessed GV reference values, and studied the correlation of GV with established glycemic indices (i.e., HbA(1c), seven-point oral glucose tolerance test [OGTT]-derived indices). Methods: We used cross-sectional data from The Maastricht Study, an observational population-based cohort enriched with type 2 diabetes. Participants with more than 48 h of CGM (iPro2; Medtronic) were included for analysis (n = 851; age: 60 +/- 9years; 49% women; 23% type 2 diabetes). We used mean sensor glucose (MSG), standard deviation (SD), and coefficient of variation (CV) as CGM-derived indices (the latter two for GV quantification). We calculated reliability using the Spearman-Brown prophecy formula, established reference values by calculating 2.5th-97.5th percentiles, and studied correlations using Spearman's rho. Results: Sufficient reliability (R > 0.80) was achieved with two (MSG and SD), or three monitoring days (CV). The reference ranges, assessed in individuals with normal glucose metabolism (n = 470), were 90.5-120.6 mg/dL (MSG), 7.9-24.8 mg/dL (SD), and 7.74%-22.45% (CV). For MSG, the strongest correlation was found with fasting plasma glucose (rho = 0.65 [0.61; 0.69]); for SD, with the 1-h OGTT value (rho = 0.61 [0.56; 0.65]); and for CV, with both the incremental glucose peak (IGP) during the OGTT (rho = 0.50 [0.45; 0.55]) and the 1-h OGTT value (rho = 0.50 [0.45; 0.55]). Conclusions: The reliability findings and reference values are relevant for studies that aim to investigate CGM-measured GV. One-hour OGTT and IGP values can be used as GV indices when CGM is unavailable.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据